Overview
GE HealthCare Technologies Inc.
Latest 10-K: FY2025, filed Feb 4, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $20.63B
- 4.8%YoYup from FY2024
- TotalRevenue
- Gross profit
- $8.25B
- 0.5%YoYup from FY2024
- GrossProfit
- Operating income
- $2.76B
- 5.3%YoYup from FY2024
- OperatingIncome
- Net income
- $2.08B
- 4.6%YoYup from FY2024
- NetIncome
- Diluted EPS
- $4.55
- 4.8%YoYup from FY2024
- EPSDiluted
- Diluted shares
- 458.0M
- 0.2%YoYdown from FY2024
- WeightedAvgSharesDiluted
At a glance
Growth
- GE HealthCare Technologies Inc. reported revenue of $20.63B for fiscal 2025, up 4.8% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 1 of the last 4 fiscal years.
Profitability
- Operating margin was 13.4% and net margin was 10.1%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.
Per share
- Diluted EPS was $4.55, up 4.8% from the prior year.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 30, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $20.63B4.8%up Benchmark median 6.4% | $19.67B0.6%up Benchmark median 4.5% | $19.55B6.6%up Benchmark median 4.8% | $18.34B4.3%up Benchmark median 10.3% | $17.59B Benchmark median 13.8% | 4.1% Benchmark median 6.6% |
| Gross Profit Median of 315 / 498 | $8.25B0.5%up Benchmark median 6.8% | $8.21B3.6%up Benchmark median 5.5% | $7.92B10.3%up Benchmark median 5.2% | $7.18B0.1%up Benchmark median 8.3% | $7.17B Benchmark median 15.7% | 3.5% Benchmark median 6.2% |
| Operating Income Median of 373 / 498 | $2.76B5.3%up Benchmark median 7.3% | $2.63B7.8%up Benchmark median 7.4% | $2.44B3.4%down Benchmark median 4.9% | $2.52B9.8%down Benchmark median 7.5% | $2.79B Benchmark median 23.5% | -0.3% Benchmark median 7.2% |
| Net Income | $2.08B4.6%up Benchmark median 4.8% | $1.99B27.1%up Benchmark median 5.7% | $1.57B18.2%down Benchmark median 1.9% | $1.92B14.7%down Benchmark median 1.3% | $2.25B Benchmark median 33.9% | -1.9% Benchmark median 4.1% |
| EPS (Diluted) | $4.554.8%up Benchmark median 6.2% | $4.3443.2%up Benchmark median 7.9% | $3.0328.2%down Benchmark median 1.9% | $4.2214.7%down Benchmark median 1.5% | $4.95 Benchmark median 34.8% | -2.1% Benchmark median 5.6% |
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $36.91B11.5%up Benchmark median 5.6% | $33.09B2.0%up Benchmark median 3.4% | $32.45B17.8%up Benchmark median 4.1% | $27.54B Benchmark median 2.2% | — | — Benchmark median 4.7% |
| Total Liabilities Median of 357 / 498 | $26.31B7.7%up Benchmark median 6.4% | $24.44B2.8%down Benchmark median 1.9% | $25.14B40.1%up Benchmark median 2.9% | $17.95B Benchmark median 2.0% | — | — Benchmark median 4.4% |
| Stockholders' Equity | $10.39B22.8%up Benchmark median 6.8% | $8.46B18.5%up Benchmark median 5.4% | $7.14B23.7%down Benchmark median 7.3% | $9.36B43.9%down Benchmark median 2.5% | $16.68B Benchmark median 9.0% | -11.2% Benchmark median 6.1% |
| Cash & Equivalents | $4.49B56.3%up Benchmark median 5.2% | $2.87B15.2%up Benchmark median 1.9% | $2.49B73.2%up Benchmark median 6.7% | $1.44B Benchmark median -8.6% | — | — Benchmark median 2.0% |
| Total Debt | $10.51B0.5%up Benchmark median 2.1% | $10.45B0.1%up Benchmark median 0.2% | $10.44B26.6%up Benchmark median 0.3% | $8.25B Benchmark median 0.1% | — | — Benchmark median 4.3% |
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.99B1.6%up Benchmark median 6.3% | $1.96B6.9%down Benchmark median 4.8% | $2.10B1.5%down Benchmark median 9.9% | $2.13B32.8%up Benchmark median -0.7% | $1.61B Benchmark median 10.7% | 5.4% Benchmark median 7.0% |
| Capital Expenditures | $482.00M20.2%up Benchmark median 5.4% | $401.00M3.6%up Benchmark median 2.8% | $387.00M24.8%up Benchmark median 11.3% | $310.00M25.0%up Benchmark median 14.0% | $248.00M Benchmark median 8.1% | 18.1% Benchmark median 9.0% |
| Free Cash Flow Median of 378 / 498 | $1.50B3.2%down Benchmark median 7.3% | $1.55B9.3%down Benchmark median 6.1% | $1.71B6.0%down Benchmark median 8.8% | $1.82B34.2%up Benchmark median -11.3% | $1.36B Benchmark median 10.2% | 2.6% Benchmark median 4.9% |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Valuation · Earnings yield
What a dollar of market value earned
5.5%
Wall Street
on net earnings
FY2024 5.6%
4.0%
Value investor
on free cash flow
FY2024 4.3%
Gap −1.5 pts: Value-investor figure 1.5 points lower
How it’s calculated
Wall Street · on net earnings
Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)
pe_ratio (ratio table)
P/E 18.0×Value investor · on free cash flow
(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)
free cash flow ÷ market cap
Valuation · Enterprise yield
What a dollar of enterprise value earned
7.0%
Wall Street
on EBITDA
FY2024 6.8%
6.3%
Value investor
on EBIT
FY2024 6.0%
Gap −0.7 pts: Value-investor figure 0.7 points lower
How it’s calculated
Wall Street · on EBITDA
EBITDA ÷ enterprise value (1 ÷ EV/EBITDA)
ev_ebitda (ratio table)
EV/EBITDA 14.3×Value investor · on EBIT
Operating income (EBIT) ÷ enterprise value: depreciation counts as a real cost
operating income ÷ (ev_ebitda × ebitda)
Valuation · Book yield
Net assets behind a dollar of market value
27.7%
Wall Street
on book equity
FY2024 23.6%
n/m
Value investor
on tangible book
FY2024 n/m
How it’s calculated
Wall Street · on book equity
Book value of equity ÷ market capitalisation (1 ÷ P/B)
pb_ratio (ratio table)
P/B 3.6×Value investor · on tangible book
Tangible book value (equity less goodwill and intangibles) ÷ market capitalisation
tangible_book_value_per_share ÷ (pb_ratio × book_value_per_share)
Quality · Return on capital
Profit earned on the money in the business
22.1%
Wall Street
ROE: net income ÷ equity
FY2024 25.5%
8.9%
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 8.8%
Gap −13.2 pts: Value-investor figure 13.2 points lower
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
14.8%
Wall Street
EBITDA margin
FY2024 14.9%
7.3%
Value investor
Free-cash-flow margin
FY2024 7.9%
Gap −7.5 pts: Value-investor figure 7.5 points lower
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
1.37×
Wall Street
Current ratio
FY2024 1.04×
1.13×
Value investor
Quick ratio, inventory excluded
FY2024 0.83×
Gap −0.24×: Value-investor figure 0.24 lower
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Balance sheet · Debt cover
How many times one year of earnings repays all debt
0.29×
Wall Street
EBITDA ÷ total debt
FY2024 0.28×
0.14×
Value investor
FCF ÷ total debt
FY2024 0.15×
Gap −0.15×: Value-investor figure 0.15 lower
How it’s calculated
Wall Street · EBITDA ÷ total debt
EBITDA ÷ total debt (short-term + long-term)
ebitda ÷ total debt
Net debt/EBITDA 1.97×Value investor · FCF ÷ total debt
Free cash flow ÷ total debt: what is actually left to repay it
free cash flow ÷ total debt
Balance sheet · Interest cover
How many times earnings pay the year's interest
5.7×
Wall Street
EBITDA ÷ interest
FY2024 5.1×
5.1×
Value investor
EBIT ÷ interest
FY2024 4.5×
Gap −0.6×: Value-investor figure 0.6 lower
How it’s calculated
Wall Street · EBITDA ÷ interest
EBITDA ÷ interest expense
ebitda_interest_coverage (ratio table)
Value investor · EBIT ÷ interest
Operating income ÷ interest expense
interest_coverage (ratio table)
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on GEHC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on GEHC and publish the result to your public profile.
Cite this page
Data as of Oct 30, 2026. Canonical address: https://valuein.biz/data/GEHC
Valuein. (2026, October 30). GE HealthCare Technologies Inc. (GEHC) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/GEHC
@misc{valuein_gehc_2026,
author = {{Valuein}},
title = {GE HealthCare Technologies Inc. (GEHC) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/GEHC}},
note = {Data as of 2026-10-30; source: SEC EDGAR filings}
}10-K filed Feb 4, 2026 · accession 0001932393-26-000007
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.